Clinical Trial VICCPED0995
Title
Detection of Donor-Derived DNA in Semen Samples Among Recipients of Allogeneic Hematopoietic Stem-Cell Transplants
Principal Investigator(s)
Details
- Protocol No. VICCPED0995
- Open Date: 02/18/2010
- Staging: NA
- Age Group: Both Child and Adult
- Scope: Local
- Objective: To examine semen samples from male survivors of allogeneic SCT for the presence of donor derived DNA
- Disease Sites: Pediatrics; Leukemia
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- National Clinical Trial ID: NCT01077440
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
|---|---|
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
DISEASE CHARACTERISTICS:
• Disease in remission
• More than 365 days since prior allogeneic hematopoietic stem cell transplantation with history of full donor engraftment
• Stable complete donor chimerism
PATIENT CHARACTERISTICS:
• Able to consent and willing to provide a semen sample
• Survivors who present for long-term follow-up appointments in the adult and pediatric stem cell transplant clinic at Vanderbilt University Medical Center
• No known history of infertility or azospermia
PRIOR CONCURRENT THERAPY:
• See Disease Characteristics
• No history of testicular irradiation ≥ 200 cGy
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
